| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/09/2008 | WO2008119254A1 New use of coccidian |
| 10/09/2008 | WO2008119203A1 A purified recombinant batroxobin with high specific activity |
| 10/09/2008 | WO2008119191A1 Microfluidic methods for the separation of supercoiled dna |
| 10/09/2008 | WO2008119136A1 Improved methods and constructs for marker free agrobacterium mediated transformatiom |
| 10/09/2008 | WO2008119134A1 Methods for producing secondary metabolites |
| 10/09/2008 | WO2008119110A1 Treatment of obesity |
| 10/09/2008 | WO2008095096A9 Let-7 microrna and mimetics thereof as therapeutics for cancer |
| 10/09/2008 | WO2008087561A8 Methods and compositions for modulating the sirna and rna-directed-dna methylation pathways |
| 10/09/2008 | WO2008085797A3 miR-16 REGULATED GENES AND PATHWAYS AS TARGETS FOR THERAPEUTIC INTERVENTION |
| 10/09/2008 | WO2008085551A3 Smallpox monoclonal antibody |
| 10/09/2008 | WO2008083393A3 Compositions and methods using split polymerases |
| 10/09/2008 | WO2008076157A3 Modified vaccinia ankara virus vaccine |
| 10/09/2008 | WO2008073498A3 Artemisinic epoxide and methods for producing same |
| 10/09/2008 | WO2008070274A3 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes |
| 10/09/2008 | WO2008064096A3 Elongase gene and uses thereof |
| 10/09/2008 | WO2008057637A3 Methods of increasing secretion of polypeptides having biological activity |
| 10/09/2008 | WO2008054612A3 Dna composition for eliciting an immune response against tumor-associated macrophages |
| 10/09/2008 | WO2008042469A3 Knockout mice for different genes and their use for gene characterizatio |
| 10/09/2008 | WO2008042235A3 Thermotoga neapolitana dsm 5068 alkaline phosphatase (phoa) gene and recombinant enzyme production |
| 10/09/2008 | WO2008041933A3 Rna interference against wrap53 to treat hyperproliferative diseases |
| 10/09/2008 | WO2008038296A3 Recombinant calcitonin fused to interleukin-2 |
| 10/09/2008 | WO2008024983A3 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions |
| 10/09/2008 | WO2008024129A3 Synthetic genomes |
| 10/09/2008 | WO2008022295A3 Prlr-specific antibody and uses thereof |
| 10/09/2008 | WO2008021457A3 Nested binary code symbol |
| 10/09/2008 | WO2008014400A3 Crohn disease susceptibility gene |
| 10/09/2008 | WO2008008793A3 Methods and compositions for degradation of lignocellulosic material |
| 10/09/2008 | WO2008008463A3 METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPβ |
| 10/09/2008 | WO2007134340A3 Designer proton-channel transgenic algae for photobiological hydrogen production |
| 10/09/2008 | WO2007123737A3 Methods and compositions for localized secretion of anti-ctla-4 antibodies |
| 10/09/2008 | WO2007112001A3 Compositions and methods for treating myocardial infarction |
| 10/09/2008 | WO2007101028A3 Method to produce enzymatically active recombinant endonucleases |
| 10/09/2008 | WO2005007867A3 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 10/09/2008 | WO2004065561A3 Methods for identifying compounds that modulate untranslated region-dependent gene expression and methods of using same |
| 10/09/2008 | US20080250535 Using vector transformation to express amino acid oxidase and phosphinothricin and preferential destroy or prevent gamete formation in plants |
| 10/09/2008 | US20080250534 Enhancing crop yield via increase activity of RNA-binding protein; improving nutrient quality of plants |
| 10/09/2008 | US20080250533 Transgenic plant with enhanced expression of UDP-glucose dehydrogenase and hyaluronan synthase; for improving nutrient quality of animal feeds |
| 10/09/2008 | US20080250532 Promoter sequence for use in controlled expression of heterologous polypeptides in plant endosperm |
| 10/09/2008 | US20080250531 Enzymes involved in triterpene synthesis |
| 10/09/2008 | US20080250530 Enhanced resistance to plant parasitic nematodes; industrial scale |
| 10/09/2008 | US20080250529 Expression vector comprising promoter sequences for use in generation of disease, insect, herbicide, drought and salt resistant plants |
| 10/09/2008 | US20080250528 Rice Glutelin Gene Promoters |
| 10/09/2008 | US20080250527 Antibiotic Resistance Conferrred by a Plant Abc Transporter Gene when Expressed in Transgenic Plants |
| 10/09/2008 | US20080250526 Stress Tolerant Transgenic Plants Over-Expressing Genes of Ascorbic Acid Synthesis-Cell Wall |
| 10/09/2008 | US20080250519 Soybean cultivar 5723264 |
| 10/09/2008 | US20080250517 Methods |
| 10/09/2008 | US20080250516 Mutant proteolytic enzyme for processing pro-growth hormone releasing factor; identifying modulators for prevention and treatment of eating disorders |
| 10/09/2008 | US20080250515 Polypeptide localization signal for enhancing bioavailability of drugs |
| 10/09/2008 | US20080250514 Expression Systems Using Mammalian Beta-Actin Promoter |
| 10/09/2008 | US20080250513 Supplying deoxyguanosine for enzymatic synthesis of deoxyribonucleosides; monoclonal/polyclonal antibodies; host cells, plants, animals |
| 10/09/2008 | US20080250512 Generating sleep disorder animal model via administering plasma constituents recovered from renal failure patients diagnosed with restless legs and /or periodic limb movement disorders |
| 10/09/2008 | US20080250511 Nucleotide sequences for use as screening tools in diagnosis of anxiety and/or depressive disorder |
| 10/09/2008 | US20080249293 Nucleic acids encoding a G-protein coupled receptor involved in sensory transduction |
| 10/09/2008 | US20080249292 Plant dihydroorotase |
| 10/09/2008 | US20080249284 Gene encoding labyrinthin, a marker for cancer |
| 10/09/2008 | US20080249283 Human leukocyte antigen amino acid sequences which recognize hepatitis viral epitopes; vaccine development; viricides |
| 10/09/2008 | US20080249129 Compositions and Methods for Treatment of Protein Misfolding Diseases |
| 10/09/2008 | US20080249083 isolated nucleic acids coding for novel glutaminyl-peptide cyclotransferase-like proteins (QPCTLs); isoenzymes; useful for the discovery of new therapeutic agents, for measuring cyclase activity; Alzheimer's disease, Familial British Dementia, Familial Danish Dementia, Down Syndrome, Huntington's disease |
| 10/09/2008 | US20080249056 agents that affect the activity and/or expression of CXCL16 can be used to alter the uptake of D-type CpG oligodeoxynucleotides; to decrease an immune response; antagonist of ADAM-10 is GW280264X, G1254023X or GM6001 |
| 10/09/2008 | US20080249052 Synthetic mini/micro-dystrophin genes to restore nNOS to the sarcolemma |
| 10/09/2008 | US20080249050 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 10/09/2008 | US20080249045 MGAL: A GAL Gene Switch-Based Suite of Methods for Protein Analyses and Protein Expression in Multicellular Organisms and Cells Therefrom |
| 10/09/2008 | US20080249042 cultured prokaryotic or eukaryotic cell transformed or transfected with expression construct; vectors; treating retinal disease or blindness |
| 10/09/2008 | US20080249041 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 10/09/2008 | US20080249040 Molecules having sense and antisense strands; metabolic and cardiovascular disorders; in vivo stability and activity |
| 10/09/2008 | US20080249039 Modified Short Interfering Rna (Modified Sirna) |
| 10/09/2008 | US20080249038 Bone Morphogenetic Protein (Bmp) 2A and Uses Thereof |
| 10/09/2008 | US20080249027 Heptapeptide having the sequence of CHEASQC; Multiple Sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis |
| 10/09/2008 | US20080249025 Peptide fragments of p21; antiproliferative agents |
| 10/09/2008 | US20080249009 ApM-1 and related proteins to influence partitioning of dietary lipids between liver and peripheral tissues; reduce free fatty acids in obese individuals; decrease body weight; atherosclerosis; insulin resistance; hypertension, microangiopathic lesions |
| 10/09/2008 | US20080248963 Hybridization Method |
| 10/09/2008 | US20080248959 Polypeptide with amino acid sequence including exogenous glycosylate sequence; libraries |
| 10/09/2008 | US20080248953 Applying purified polypeptide that is a bacteriocin and possesses plant growth and/or disease resistance promoting activity to a plant or plant seed |
| 10/09/2008 | US20080248576 Genetic Inhibition of double-stranded RNA |
| 10/09/2008 | US20080248575 Drug and Gene Delivery by Polymer Nanonozzle and Nanotip Cell Patch |
| 10/09/2008 | US20080248574 Therapeutic polypeptide comprising cell entry doman for use in treatment of cell proliferative disorders; enhancing metastaic tumor sensitivity to oxidative stress |
| 10/09/2008 | US20080248568 Propagating pluripotent cells in nutrient broth, activating notch signaling, recovering nervous system tissues; tissue engineering and regenerative medicine |
| 10/09/2008 | US20080248566 Matriptase, a serine protease and its applications |
| 10/09/2008 | US20080248564 Novel property effecting and/or property exhibiting compositions for therapeutic and diagnostic uses |
| 10/09/2008 | US20080248559 Method For Selectively Separating and Purifying Rna and Method For Separating and Purifying Nucleic Acid |
| 10/09/2008 | US20080248553 Recombinant food-grade microorganism for use as bioreactor in production of monoglutamyl folate |
| 10/09/2008 | US20080248547 Novel glyphosate-N-acetyltransferase (GAT) genes |
| 10/09/2008 | US20080248546 Oxidoreductase comprising enhanced thermal stability, solvent tolerance and hydrogen ion concentration optimum for use in converting glucose to ascorbic acid |
| 10/09/2008 | US20080248545 Modified cytochrome p450 for use as tool in identifying carcinogenic agents |
| 10/09/2008 | US20080248544 Methods And Compositions For Grafting Functional Loops Into A Protein |
| 10/09/2008 | US20080248538 From Pseudomonas putida or Pseudomonas marginalis strains; probes |
| 10/09/2008 | US20080248533 method for in vitro molecular evolution of protein function |
| 10/09/2008 | US20080248531 Preparation of fully human antibodies |
| 10/09/2008 | US20080248529 Expression vector comprising nucleotide sequences coding lymphocyte surface protein specific immunoglobulin for use in treatment of cell proliferative, inflammatory and autoimmune diseases |
| 10/09/2008 | US20080248528 Erythrovirus and its applications |
| 10/09/2008 | US20080248527 Binding amino acid sequences for use in targeting stains on textiles; enhancing cleaning performance of detergents |
| 10/09/2008 | US20080248525 Twin-Arginine translocation in bacillus |
| 10/09/2008 | US20080248524 AMP Deaminase Originating Streptomyces And Utilization Thereof |
| 10/09/2008 | US20080248523 Utilisation of Constructs Comprising Recombination Sequence Motifs for Enhancing Gene Expression in Moss |
| 10/09/2008 | US20080248496 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 10/09/2008 | US20080248495 Protease Activated Receptor (PAR) activating peptide for use as screening tool in identifying modulators for treatment of thrombosis |
| 10/09/2008 | US20080248494 Diagnosing menopause via follicle stimulating hormone specfic immunoglobulins |
| 10/09/2008 | US20080248489 Methods and compositions for directed microwave chemistry |
| 10/09/2008 | US20080248479 Methods for Isolating and Characterizing Endogenous mRNA-Protein (mRNP) Complexes |
| 10/09/2008 | US20080248477 Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses therefor |